BetterLife Pharma (BETRF) Restructuring Costs (2021 - 2022)
BetterLife Pharma (BETRF) posted quarterly Restructuring Costs of $116629.1 for Q3 2022, up 213.85% year-over-year from $37160.6 in Q3 2021, and up 37.14% quarter-over-quarter from $85043.0 in Q2 2022.
BetterLife Pharma (BETRF) Restructuring Costs (2021 - 2022) Analysis & Trends
BetterLife Pharma's Restructuring Costs history runs 2 years deep, the most recent figure standing at $116629.1 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2022 | 116,629.07 |
| Apr 30, 2022 | 85,042.98 |
| Oct 31, 2021 | -49,997.24 |
| Jul 31, 2021 | -102,439.77 |